Welcome to CSNpharm! For Research Use Only!
Cannabinoid Receptor
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN21516 | β-Caryophyllene | 87-44-5 | β-Caryophyllene is an agonist of the cannabinoid (CB) receptor CB2 with Ki of 155 nM. |
| CSN18972 | Taranabant (1R,2R)stereoisomer | 701977-08-4 | Taranabant1R2Rstereoisomer is the R-Enantiomer of taranabant Taranabant is a highly potent and selective cannabinoid 1 CB1 receptor inverse agonist |
| CSN12382 | Taranabant | 701977-09-5 | Taranabant is a cannabinoid 1 receptor inverse agonist with IC50 of 03 nM |
| CSN22151 | MK-9470 | 947371-30-4 | MK-9470 is a selective high-affinity inverse agonist human IC5007 nM for the cannabinoid CB1 receptor CB1R developed for use in human brain imaging |
| CSN13453 | MDA 19 | 1048973-47-2 | MDA 19 is a selective human CB2 receptor agonist with Ki of 433 nM |
| CSN25339 | MAFP | 188404-10-6 | MAFP is a potent, irreversible inhibitor of fatty acid amide hydrolase (FAAH, anandamide amidase), the enzyme responsible for anandamide hydrolysis (IC50 = 2.5 nM). MAFP also binds irreversibly to CB1 receptors with IC50 of 20 nM. |
| CSN19472 | LY320135 | 176977-56-3 | LY-320135 is a potent and selective Canniboid CB1 receptor antagonistinverse agonist. LY-320135 is selective (70 fold) over Canniboid CB2 receptors. This compound shows weak binding to both 5-HT2 (Ki 6.4 M) and muscarinic receptors (Ki 2.1 M). |
| CSN20218 | JD5037 | 1392116-14-1 | JD-5037 is a peripherally restricted CB1R antagonist with an IC50 of 15 nM |
| CSN19173 | GW842166X | 666260-75-9 | GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM shows no significant activity at CB1 receptor |
| CSN21228 | CB2R-IN-1 | 1257555-79-5 | CB2R-IN-1 is a potent cannabinoid CB2 receptor inverse agonist with a Ki of 09 nM |
| CSN20330 | CB2 Agonist C8 | 2052602-31-8 | CB2 agonist C8 is an agonists of cannabinoid receptor type 2 |
| CSN20331 | CB2 Agonist C36 | 2097512-96-2 | CB2 agonist C36 is an agonists of cannabinoid receptor type 2 |
| CSN17330 | CB1-IN-1 | 1429239-98-4 | CB1-IN-1 is a peripherally restricted CB1R antagonist, with Ki of 0.3 nM and 21 nM for CB1R (EC50 = 3 nM) and CB2R, respectively. |
| CSN20616 | Cannabidivarin | 24274-48-4 | Cannabidivarin is a non-psychoactive cannabinoid found in Cannabis that activates CB2 cannabinoid receptors as well as the transient receptor potential channels TRPA1, TRPV1, and TRPV2 (EC50s 0.42, 3.6, and 7.3 M, respectively). It is also reported to antagonize TRPM8 (IC50 0.9 M) and to inhibit diacylglycerol lipase (IC50 16.6 M). |
| CSN10421 | beta-Amyrin | 559-70-6 | beta-Amyrin, a natural cannabinoid receptors agonist isolated and purified from the stem bark of Alstonia boonei, has anti-inflammatory activity. Beta-Amyrin significantly inhibits PGE2, IL-6 secretion, and NF-B activation in a concentration-dependent manner on LPS-induced hPBMCs. |
| CSN15642 | beta-Amyrin Acetate | 1616-93-9 | beta-Amyrin acetrate, a natural cannabinoid receptor isolated and purified from the herbs of Alstonia boone, shows significant HMG-CoA-reductase and sEH inhibitory activities. |
| CSN18739 | BAY 59-3074 | 406205-74-1 | Bay 59-3074 is a selective CB1CB2 receptor partial agonist with Kis of 483 and 455 nM at human CB1 and CB2 receptors respectively |
| CSN21999 | (±)-SLV319 | 362519-49-1 | -SLV319 is a selective antagonist of cannabinoid-1 CB1 receptor with Ki value of 78 nM and it has a weaker activation effect on CB2 |
| CSN15641 | (+)-Gallocatechin | 970-73-0 | -Gallocatechin a natural product isolated and purified from the wood of Acacia catechu LF Willd has moderate affinity to the human cannabinoid receptor |
| CSN12783 | (-)-Gallocatechin | 3371-27-5 | --Gallocatechin a natural product isolated and purified from the wood of Acacia catechu LF Willd has moderate affinity to the human cannabinoid receptor |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
